Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine: Lyon, France Saturday, July 12, 2025, 18:00 Hrs [IST] Osivax ...

Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...